trimetazidine has been researched along with Coronary Artery Disease in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 13 (39.39) | 29.6817 |
| 2010's | 13 (39.39) | 24.3611 |
| 2020's | 7 (21.21) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, ZL; Gao, WL; Li, Y; Lin, J; Lin, M; Song, YF; Tian, Y; Wang, P; Wang, Q | 1 |
| Chen, C | 1 |
| He, J; Jin, C; Li, Y; Luan, Y; Wang, M; Wu, L; Zhang, W | 1 |
| Fang, Y; Zheng, YS; Zhu, K | 1 |
| Mahajan, AU; Mahajan, S | 1 |
| Chen, W; Wang, C; Yang, P; Yu, M | 1 |
| Balan, A; Bobescu, E; Covaciu, A; Dima, L; Marceanu, LG; Strempel, CG | 1 |
| Gaszner, B; Hild, G; Kónyi, A; Meiszterics, Z; Sárszegi, Z | 1 |
| Challeton, JP; Danchin, N; Ferrari, R; Ford, I; Fox, K; Marzilli, M; Tendera, M; Widimský, P | 1 |
| Fi, Z; Kovács, G; Szentes, V | 1 |
| Bocchi, EA; Costa, LMA; Filho, RK; Garcia, RMR; Hueb, W; Krieger, JE; Ramires, JAF; Rezende, PC; Scudeler, TL; Seguro, LFBC; Uchida, AH | 1 |
| Chen, W; Li, W; Liu, W; Ming, Q; Shen, J; Wei, Y; Xu, Y | 1 |
| Blum, A | 1 |
| Bakovic, D; Bulat, C; Cavar, M; Dujic, Z; Fabijanic, D; Karanovic, N; Kraljevic, J; Lavie, CJ; Ljubkovic, M; Marinovic, J; Wisloff, U | 1 |
| Ambrosio, G; Grant, PJ; Tamargo, J | 1 |
| Danikiewicz, A; Gąsior, M; Hudzik, B; Korzonek-Szlacheta, I; Szkodziński, J; Zubelewicz-Szkodzińska, B | 1 |
| Cen, XJ; Ding, YH; Huang, DS; Jin, QY; Qian, LY; Zhu, XX; Zou, H | 1 |
| Glezer M, G; On Behalf Of The Choice-Study Participants, OB | 1 |
| Di Napoli, P | 1 |
| César, LA; Gowdak, LH; Mansur, AP | 1 |
| Cera, M; Fragasso, G; Margonato, A; Montanaro, C; Salerno, A; Spoladore, R | 1 |
| Cho, GY; Kim, HS; Kim, MK; Park, DW; Park, JH; Park, KH; Park, WJ | 1 |
| Cho, GY; Choi, YJ; Kim, HS; Kim, MK; Park, DW; Park, KH; Park, WJ | 1 |
| Godard, S; Haïat, R; Hanania, G; Maalouf, B; Martelet, M; Michel, D; Olive, T | 1 |
| Altinbas, A; Dogan, A; Ergene, O; Gedikli, O; Ozaydin, M | 1 |
| Biggi, A; Feola, M; Ferrero, V; Francini, A; Leonardi, G; Ribichini, F; Uslenghi, E | 1 |
| Lupanov, VP; Matveeva, MA; Mironova, IIu; Naumov, VG; Orlova, EM; Samoĭlenko, LE | 1 |
| Alcalá López, J; Gil Polo, B; Maicas Bellido, C; Rodríguez Padial, L; Velázquez Martín, M | 1 |
| Arroyo Espliguero, R; Cosín Sales, J; Kaski, JC | 1 |
| Biggi, A; Feola, M; Francini, A; Leonardi, G; Ribichini, F; Uslenghi, E; Vado, A | 1 |
| Cai, JS; Peng, ZJ | 1 |
| Fini, M; Gebara, O; Marazzi, G; Patrizi, R; Pelliccia, F; Pierri, H; Ramires, JA; Rosano, GM; Vitale, C; Volterrani, M; Wajngarten, M | 1 |
| Calori, G; Chierchia, S; Fragasso, G; Lu, C; Margonato, A; Monti, L; Palloshi, A; Piatti, PM; Pozza, G; Setola, E; Valsecchi, G | 1 |
8 review(s) available for trimetazidine and Coronary Artery Disease
| Article | Year |
|---|---|
Current Clinical Evidence of Trimetazidine in the Management of Heart Disease in Patients with Diabetes.
Topics: Coronary Artery Disease; Diabetes Mellitus; Humans; Myocardial Ischemia; Trimetazidine; Vasodilator Agents | 2020 |
Efficacy of Trimetazidine in Limiting Periprocedural Myocardial Injury in Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.
Topics: Biomarkers; Cardiovascular Agents; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Myocardial Reperfusion Injury; Myocardium; Percutaneous Coronary Intervention; Randomized Controlled Trials as Topic; Recovery of Function; Risk Factors; Stroke Volume; Treatment Outcome; Trimetazidine; Troponin I; Ventricular Function, Left | 2021 |
[Role of trimetazidine in the treatment of diabetic microangiopathy in ischaemic heart disease].
Topics: Angina Pectoris; Anti-Inflammatory Agents, Non-Steroidal; Coronary Artery Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Heart; Humans; Myocardial Infarction; Myocardial Ischemia; Myocardium; Trimetazidine; Vasodilator Agents | 2015 |
Non-haemodynamic anti-anginal agents in the management of patients with stable coronary artery disease and diabetes: A review of the evidence.
Topics: Animals; Cardiovascular Agents; Coronary Artery Disease; Diabetes Mellitus; Humans; Ranolazine; Trimetazidine; Vasodilator Agents | 2016 |
Trimetazidine in conditions other than coronary disease, old drug, new tricks?
Topics: Acetyl-CoA C-Acyltransferase; Antineoplastic Agents; Chemically-Induced Disorders; Coronary Artery Disease; Diabetic Cardiomyopathies; Drug Repositioning; Humans; Kidney Diseases; Mitochondria, Heart; Trimetazidine; Vasodilator Agents | 2017 |
The metabolic treatment of patients with coronary artery disease: effects on quality of life and effort angina.
Topics: Acetanilides; Angina Pectoris; Animals; Carnitine; Clinical Trials as Topic; Coronary Artery Disease; Dichloroacetic Acid; Humans; Piperazines; Quality of Life; Ranolazine; Ribose; Surveys and Questionnaires; Trimetazidine; Vasodilator Agents | 2009 |
Effects of metabolic approach in diabetic patients with coronary artery disease.
Topics: Acetyl-CoA C-Acyltransferase; Carnitine O-Palmitoyltransferase; Coronary Artery Disease; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Glucose; Humans; Trimetazidine; Vasodilator Agents; Ventricular Dysfunction, Left | 2009 |
Silent myocardial ischaemia: clinical relevance and treatment.
Topics: Acetyl-CoA C-Acyltransferase; Animals; Coronary Artery Disease; Electrocardiography; Enzyme Inhibitors; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Myocardial Ischemia; Myocardial Revascularization; Nitric Oxide Donors; Randomized Controlled Trials as Topic; Trimetazidine; Vasodilator Agents | 2005 |
12 trial(s) available for trimetazidine and Coronary Artery Disease
| Article | Year |
|---|---|
Trimetazidine offers myocardial protection in elderly coronary artery disease patients undergoing non-cardiac surgery: a randomized, double-blind, placebo-controlled trial.
Topics: Aged; China; Coronary Artery Disease; Double-Blind Method; Female; Humans; Male; Middle Aged; Postoperative Complications; Risk Factors; Surgical Procedures, Operative; Time Factors; Treatment Outcome; Trimetazidine; Vasodilator Agents | 2021 |
Effects of trimetazidine on ventricular remodeling in coronary artery disease patients with left ventricular hypertrophy: the rationale and design of a randomized controlled trial.
Topics: Adolescent; Adult; Aged; Cardiovascular Agents; China; Coronary Artery Disease; Female; Humans; Hypertrophy, Left Ventricular; Male; Middle Aged; Percutaneous Coronary Intervention; Prospective Studies; Randomized Controlled Trials as Topic; Recovery of Function; Time Factors; Treatment Outcome; Trimetazidine; Ventricular Function, Left; Ventricular Remodeling; Young Adult | 2020 |
A randomized, double-blind, placebo-controlled trial to assess the efficAcy and safety of Trimetazidine in patients with angina pectoris having been treated by percutaneous coronary intervention (ATPCI study): Rationale, design, and baseline characteristi
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Coronary Artery Disease; Double-Blind Method; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Placebos; Postoperative Complications; Recurrence; Trimetazidine; Vasodilator Agents; Young Adult | 2019 |
Trimetazidine Prevention of Contrast-Induced Nephropathy in Coronary Angiography.
Topics: Aged; Contrast Media; Coronary Angiography; Coronary Artery Disease; Creatinine; Cystatin C; Drug Monitoring; Female; Fluid Therapy; Humans; Kidney Function Tests; Male; Middle Aged; Protective Agents; Renal Insufficiency, Chronic; Secondary Prevention; Treatment Outcome; Trimetazidine | 2015 |
Effects of trimetazidine on interleukin-2 and interleukin-8 concentrations in patients with coronary artery disease.
Topics: Adult; Coronary Artery Disease; Exercise; Female; Humans; Interleukin-2; Interleukin-8; Male; Middle Aged; Stress, Physiological; Trimetazidine | 2017 |
Effects of trimetazidine on endothelial dysfunction after sheath injury of radial artery.
Topics: Catheterization, Peripheral; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Endothelium, Vascular; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prognosis; Radial Artery; Time Factors; Trimetazidine; Vasodilation; Vasodilator Agents | 2010 |
Effects of sheath injury and trimetazidine on endothelial dysfunction of radial artery after transradial catheterization.
Topics: Aged; Cardiac Catheterization; Case-Control Studies; Coronary Angiography; Coronary Artery Disease; Endothelium, Vascular; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Radial Artery; Trimetazidine; Vasodilator Agents | 2012 |
[Coronary artery disease observed in general hospitals: ETTIC study. Comparison between trimetazidine and mononitrate isosorbide for patients receiving betablockers].
Topics: Adrenergic beta-Antagonists; Aged; Atenolol; Coronary Artery Disease; Drug Therapy, Combination; Exercise Test; Hospitals, General; Humans; Isosorbide Dinitrate; Middle Aged; Treatment Outcome; Trimetazidine; Vasodilator Agents | 2002 |
Placebo or trimetazidine (99m)Tc tetrofosmin myocardial SPECT and low-dose dobutamine echocardiography in hibernating myocardium.
Topics: Adult; Aged; Aged, 80 and over; Cardiotonic Agents; Coronary Angiography; Coronary Artery Disease; Dobutamine; Echocardiography; Female; Follow-Up Studies; Heart; Humans; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Trimetazidine; Vasodilator Agents; Ventricular Dysfunction, Left | 2006 |
[Effect of trimitazidine on insulin resistance in patients with coronary heart disease].
Topics: Adult; Blood Glucose; Cohort Studies; Coronary Artery Disease; Female; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Treatment Outcome; Trimetazidine; Vasodilator Agents | 2006 |
Effect of free fatty acid inhibition on silent and symptomatic myocardial ischemia in diabetic patients with coronary artery disease.
Topics: Aged; Coronary Artery Disease; Diabetes Mellitus, Type 2; Double-Blind Method; Electrocardiography, Ambulatory; Fatty Acids, Nonesterified; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Oxidation-Reduction; Trimetazidine; Vasodilator Agents | 2007 |
Acute effects of heparin administration on the ischemic threshold of patients with coronary artery disease: evaluation of the protective role of the metabolic modulator trimetazidine.
Topics: Aged; Analysis of Variance; Anticoagulants; Biomarkers; Blood Pressure; Coronary Artery Disease; Double-Blind Method; Electrocardiography; Endothelin-1; Exercise Test; Fatty Acids, Nonesterified; Heart Rate; Heparin; Humans; Lactic Acid; Male; Middle Aged; Nitric Oxide; Sensory Thresholds; Treatment Outcome; Trimetazidine; Vasodilator Agents | 2002 |
13 other study(ies) available for trimetazidine and Coronary Artery Disease
| Article | Year |
|---|---|
Protection of Ivabradine Combined with Trimetazidine on Myocardial Injury after Percutaneous Coronary Intervention in Patients with Coronary Artery Disease Evaluated by Magnetic Resonance Image under Convolutional Neural Network.
Topics: Aged; Aged, 80 and over; Artificial Intelligence; Coronary Artery Disease; Female; Heart; Heart Injuries; Humans; Ivabradine; Magnetic Resonance Imaging; Male; Middle Aged; Myocardium; Neural Networks, Computer; Percutaneous Coronary Intervention; Trimetazidine | 2021 |
Effect of trimetazidine on incidence of major adverse cardiac events in coronary artery disease patients undergoing percutaneous coronary intervention: A protocol for systematic review and meta-analysis.
Topics: Cardiotonic Agents; Coronary Artery Disease; Humans; Meta-Analysis as Topic; Percutaneous Coronary Intervention; Postoperative Complications; Research Design; Systematic Reviews as Topic; Treatment Outcome; Trimetazidine; Vasodilator Agents | 2020 |
Trimetazidine Therapy in Coronary Artery Disease: The Impact on Oxidative Stress, Inflammation, Endothelial Dysfunction, and Long-Term Prognosis.
Topics: Acute Coronary Syndrome; Coronary Artery Disease; Humans; Inflammation; Oxidative Stress; Prognosis; Prospective Studies; Trimetazidine | 2021 |
Effectiveness and safety of anti-ischemic trimetazidine in patients with stable angina pectoris and Type 2 diabetes.
Topics: Aged; Angina, Stable; Canada; Coronary Artery Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Administration Schedule; Female; Humans; Male; Myocardial Ischemia; Prospective Studies; Pulse Wave Analysis; Trimetazidine; Vasodilator Agents | 2017 |
Role of Trimetazidine in Ischemic Preconditioning in Patients With Symptomatic Coronary Artery Disease.
Topics: Aged; Coronary Artery Disease; Drug Monitoring; Electrocardiography; Exercise Test; Female; Humans; Ischemic Preconditioning; Male; Middle Aged; Outcome Assessment, Health Care; Patient Acuity; Prospective Studies; Trimetazidine; Vasodilator Agents | 2015 |
New oral nitric oxide-dependent medications for patients with coronary artery disease who have persistent angina pectoris.
Topics: Administration, Oral; Angina, Stable; Coronary Artery Disease; Humans; Nitric Oxide; Ranolazine; Sodium Channel Blockers; Trimetazidine; Vasodilator Agents | 2015 |
Trimetazidine does not alter metabolic substrate oxidation in cardiac mitochondria of target patient population.
Topics: Aged; Coronary Artery Disease; Female; Humans; Male; Mitochondria, Heart; Oxidation-Reduction; Palmitoylcarnitine; Pyruvic Acid; Trimetazidine | 2016 |
[Treatment of Patients With Stable Ischemic Heart Disease in Real Clinical Practice in Russia. The CHOICE-2 Program].
Topics: Angina Pectoris; Coronary Artery Disease; Humans; Myocardial Ischemia; Russia; Trimetazidine | 2016 |
The metabolic treatment of coronary artery disease and heart failure.
Topics: Carnitine O-Palmitoyltransferase; Coronary Artery Disease; Epoxy Compounds; Heart Failure; Humans; Perhexiline; Trimetazidine; Vasodilator Agents | 2009 |
Effect of trimetazidine on exercise performance in patients with coronary artery ectasia.
Topics: Aged; Angina Pectoris; Coronary Artery Disease; Coronary Circulation; Dilatation, Pathologic; Electrocardiography; Exercise Test; Humans; Male; Middle Aged; Trimetazidine; Vasodilator Agents | 2003 |
Trimetazidine improves myocardial perfusion and left ventricular function in ischemic left ventricular dysfunction.
Topics: Aged; Coronary Artery Disease; Coronary Vessels; Gated Blood-Pool Imaging; Heart Ventricles; Humans; Male; Myocardial Infarction; Myocardial Ischemia; Single-Blind Method; Stroke Volume; Treatment Outcome; Trimetazidine; Vasodilator Agents; Ventricular Dysfunction, Left | 2004 |
[Assessment of antianginal and antiischemic effect of trimetazidine and its effects on myocardial perfusion in patients with ischemic heart disease and stable angina.].
Topics: Angina Pectoris; Angina, Stable; Coronary Artery Disease; Humans; Myocardial Ischemia; Trimetazidine; Vasodilator Agents | 2004 |
[Limited application of prevention measures in patients with diabetes mellitus type 2 and coronary artery disease in Spain. DIETRIC study].
Topics: Aged; Coronary Artery Disease; Diabetes Mellitus, Type 2; Female; Humans; Male; Middle Aged; Risk Factors; Spain; Trimetazidine; Vasodilator Agents | 2005 |